Classification and definition of major flares in SLE clinical trials.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 685, doi. 10.1191/096120399680411281
- By:
- Publication type:
- Article
Works matching IS 09612033 AND DT 1999 AND VI 8 AND IP 8
Results: 19
1
2
Assessing disease activity in SLE patients during pregnancy.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 677, doi. 10.1191/096120399680411272
- By:
- Publication type:
- Article
3
A conceptual framework for clinical trials in SLE and other multisystem diseases.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 570, doi. 10.1191/096120399680411290
- By:
- Publication type:
- Article
4
Equivalence trials in SLE research: issues to consider.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 620, doi. 10.1191/096120399680411308
- By:
- Publication type:
- Article
5
The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: Strengths, weaknesses, and opportunities for improvement.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 586, doi. 10.1191/096120399680411317
- By:
- Publication type:
- Article
6
Sample size considerations for superiority trials in systemic lupus erythematosus (SLE).
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 612, doi. 10.1191/096120399680411326
- By:
- Publication type:
- Article
7
The SLICC/ACR damage index: progress report and experience in the field.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 632, doi. 10.1191/096120399680411335
- By:
- Publication type:
- Article
8
Quality of life and economic evaluation in SLE clinical trials.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 645, doi. 10.1191/096120399680411344
- By:
- Publication type:
- Article
9
Ensuring reliability of clinical assessments for SLE trials.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 671, doi. 10.1191/096120399680411353
- By:
- Publication type:
- Article
10
Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trials.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 660, doi. 10.1191/096120399680411362
- By:
- Publication type:
- Article
11
Recruitment strategies in superiority trials in SLE: lessons from the study of methotrexate in lupus erythematosus (SMILE).
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 606, doi. 10.1191/096120399680411371
- By:
- Publication type:
- Article
12
Early stopping of clinical trials in lupus and other uncommon rheumatologic diseases.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 698, doi. 10.1191/096120399680411380
- By:
- Publication type:
- Article
13
GUEST EDITORS' FOREWORD.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 569, doi. 10.1191/096120399680411399
- By:
- Publication type:
- Article
14
Methodological issues of corticosteroid use in SLE clinical trials.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 692, doi. 10.1191/096120399680411407
- By:
- Publication type:
- Article
15
Responsiveness and sensitivity to change of SLE disease activity measures.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 655, doi. 10.1191/096120399680411416
- By:
- Publication type:
- Article
16
Development of an FDA guidance document for clinical trials in SLE.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 581, doi. 10.1191/096120399680411425
- By:
- Publication type:
- Article
17
World Wide Web: Opportunities, challenges, and threats.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 596, doi. 10.1191/096120399680411434
- By:
- Publication type:
- Article
18
Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 638, doi. 10.1191/096120399680411443
- By:
- Publication type:
- Article
19
Response and remission criteria for clinical trials in lupus—what can we learn from other diseases?
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 627, doi. 10.1191/096120399680411452
- By:
- Publication type:
- Article